Alterations of Gut Microbiota in Pyogenic Liver Abscess Patients with and without Type 2 Diabetes Mellitus
DOI: https://doi.org/10.2147/idr.s456423
2024-05-29
Infection and Drug Resistance
Abstract:Shanshan Liu, 1, 2 Xiaomeng Ge, 3 Xizhan Xu, 4 Kang Zhang, 1 Xinxin Lu 1 1 Department of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Infection Management, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Jiangsu, People's Republic of China; 3 Microbial Resources and Big Data Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China; 4 Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China Correspondence: Xinxin Lu, Department of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, No. 1, Dongjiaomin Lane, Dongcheng District, Beijing, 100730, People's Republic of China, Tel +86-13911682566, Fax +8610-65125617, Email Purpose: The clinical manifestations of pyogenic liver abscess (PLA) vary between patients with and without diabetes mellitus (DM). However, the relationship between PLA and the gut microbiome remains unknown. This study analyzed the composition of gut microbiota in PLA patients with and without DM and healthy controls (HCs) with the goal of identifying potential reasons for the observed variations in clinical manifestations. Patients and Methods: Using 16S ribosomal RNA(16S rRNA) gene sequencing, we analyzed the compositions of gut microbiota in 32 PLA patients with DM, 32 PLA patients without DM, and 29 matched HCs. Results: In PLA patients with DM, the D-dimer level, fibrinogen degradation products, and thrombin time were significantly higher compared to the PLA patients without DM ( P < 0.05). The abundance and diversity of intestinal flora were reduced in both groups of PLA patients compared with the HCs ( P < 0.05). Specifically, the PLA patients with DM showed significant decreases in the relative abundances of Bacteroides, Blautia, Prevotella9 , and Faecalibacterium , whereas Enterococcus and Escherichia-Shigella were relatively more abundant ( P < 0.05). Compared to PLA patients without DM, those with DM had lower relative abundances of Lactobacillus and Klebsiella ( P < 0.05) and showed different bacterial flora, including Anaerosporobacter and Megamonas . Conclusion: PLA patients with DM exhibited more severe clinical manifestations of PLA compared to patients without DM. It is important to monitor blood coagulation in PLA patients with DM to prevent the development of thrombotic diseases. Additionally, PLA patients with DM exhibit distinct differences in the composition and diversity of their intestinal flora compared to both PLA patients without DM and HCs. Keywords: Gut microbiota, Pyogenic liver abscess, type 2 diabetes mellitus, 16S rRNA sequencing Pyogenic liver abscess (PLA) is an infectious disease caused by pyogenic bacteria that invade the liver through various routes and form solitary or multiple collections of pus within the liver. 1,2 In recent years, there has been a noticeable rise in the incidence rate of PLA in adults in China and Korea. 3–5 The incidence of liver abscesses is also on the rise among children in the United States. 6 Patients with PLA do not typically present with specific symptoms. However, if the infection is not effectively managed, it can progress to disseminated infection, sepsis, and potentially death, especially in individuals with type 2 diabetes mellitus (T2DM). 5,7,8 PLA patients with DM tend to experience more severe symptoms compared to PLA patients without DM. 9,10 Over 140 million Chinese adults were estimated to have diabetes in 2021, and this number is projected to increase to over 174 million by 2045. 11 Therefore, effective strategies for PLA prevention and treatment are urgently needed. The gut microbiota plays a significant role in host metabolism, protection against microbial invasion, and nutrient absorption, thereby exerting a profound effect on human health and disease. 12,13 Gut microbiota dysbiosis can be linked to the pathogeneses of chronic liver diseases such as chronic hepatitis B and C, liver cirrhosis, and hepatocellular carcinoma. 14–16 Alterations in the diversity of the gut microbiota have been observed in animal models of liver abscess. 17–19 Changes in the composition of pus (pus collection were as described in a previous study) microbiota are associated with the development of PLA in patients with DM. 20,21 In addition, t -Abstract Truncated-
pharmacology & pharmacy,infectious diseases